<!-- CoverPageHeader start -->
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
<TITLE> TransEnterix, Inc. (Form: 8-K) </TITLE>
</HEAD>
<BODY TEXT="#000000" BGCOLOR="#FFFFFF" ALINK="#0000FF" HLINK="#FF0000" VLINK="#800080">
<!-- Comment1 -->
<A NAME="DOCUMENT_TOP">&nbsp;</A>
<P>
<!-- CoverPageHeader end --><!-- CoverPageTitle START -->
<A NAME="DOCUMENT_TOP">&nbsp;</A>
<HR NOSHADE>
<P>
<P ALIGN="CENTER">
<FONT SIZE="4">
		UNITED STATES<BR>
	SECURITIES AND EXCHANGE COMMISSION
</FONT>
<BR>
<FONT SIZE="2">
	WASHINGTON, D.C. 20549
</FONT>
<P ALIGN="CENTER">
<FONT SIZE="5">
	FORM 8-K
</FONT>
<FONT SIZE="2">

</FONT>
</P>
<P ALIGN="CENTER">
<FONT SIZE="3">
	CURRENT REPORT
</FONT>
</P>
<P ALIGN="CENTER">
<FONT SIZE="2">
	Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934
</FONT>
</P>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
<TR VALIGN="BOTTOM">
<TD WIDTH="51%">
	&nbsp;
</TD>
<TD WIDTH="5%">
	&nbsp;
</TD>
<TD WIDTH="44%">
	&nbsp;
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	Date of Report (Date of Earliest Event Reported):
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	February 20, 2015
</FONT>
</TD>
</TR>
</TABLE>
<BR>
</CENTER>
<!-- CoverPageTitle END --><!-- CoverPageRegistrant START -->
<P ALIGN="CENTER"><!-- -->
<FONT SIZE="6">
	TransEnterix, Inc.
</FONT>
<FONT SIZE="2">
<BR>__________________________________________<BR>
	(Exact name of registrant as specified in its charter)
</FONT>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
<TR VALIGN="BOTTOM">
<TD WIDTH="33%">
	&nbsp;
</TD>
<TD WIDTH="34%">
	&nbsp;
</TD>
<TD WIDTH="33%">
	&nbsp;
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	Delaware
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	0-19437
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	11-2962080
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
_____________________<BR>
	(State or other jurisdiction
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
_____________<BR>
	(Commission
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
______________<BR>
	(I.R.S. Employer
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	of incorporation)
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	File Number)
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	Identification No.)
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	635 Davis Drive, Suite 300, Morrisville, North Carolina
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	27560
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
_________________________________<BR>
	(Address of principal executive offices)
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
___________<BR>
	(Zip Code)
</FONT>
</TD>
</TR>
</TABLE>
</CENTER>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">

<TR VALIGN="BOTTOM">
<TD WIDTH="51%">
	&nbsp;
</TD>
<TD WIDTH="5%">
	&nbsp;
</TD>
<TD WIDTH="44%">
	&nbsp;
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	Registrant&#146;s telephone number, including area code:
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	919-765-8400
</FONT>
</TD>
</TR>
</TABLE>
</CENTER>
<P ALIGN="CENTER">
<FONT SIZE="2">
	Not Applicable
<BR>______________________________________________<BR>
	Former name or former address, if changed since last report
</FONT>
<P ALIGN="CENTER">
<FONT SIZE="2">
	&nbsp;
</FONT>
<!-- CoverPageRegistrant END --><P><FONT SIZE="2">
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:</FONT>
</P>
<P><FONT SIZE="2">
[&nbsp;&nbsp;]&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<br>
[&nbsp;&nbsp;]&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<br>
[&nbsp;&nbsp;]&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<br>
[&nbsp;&nbsp;]&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<br>
</P></FONT><!-- PageBreak START -->
<P>
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<A HREF="#DOCUMENT_TOP">
<U>
<B>
<FONT SIZE="2">Top of the Form</FONT>
</B>
</U>
</A>
</DIV>
<!-- PageBreak END -->



<P align="left" style="font-size: 10pt"><FONT style="font-size: 10pt"><B>Item&nbsp;1.01 Entry into a Material Definitive Agreement.</B>
</FONT>

<P align="left" style="font-size: 10pt">On February&nbsp;20, 2015, TransEnterix, Inc. (the &#147;<U>Company</U>&#148;) entered into a Controlled Equity
Offering<sup>SM</sup> Sales Agreement (the &#147;<U>Sales Agreement</U>&#148;) with Cantor Fitzgerald & Co.
(&#147;<U>Cantor</U>&#148;) pursuant to which the Company may sell from time to time, at its option, up to
an aggregate of $25.0&nbsp;million of shares of the Company&#146;s common stock, $0.001 par value per share
(the &#147;<U>Common Stock</U>&#148;), through Cantor, as sales agent (the &#147;<U>ATM Offering</U>&#148;). Pursuant
to the Sales Agreement, sales of the Common Stock, if any, will be made under the Company&#146;s
previously filed and currently effective Registration Statement on Form S-3 (File No.&nbsp;333-199998),
at market prices by any method that is deemed to be an &#147;at the market&#148; offering as defined in Rule
415 under the Securities Act, as amended (the &#147;Securities Act&#148;), including sales made directly on
the NYSE MKT and any other trading market for the Common Stock, and sales to or through a market
maker other than on an exchange.


<P align="left" style="font-size: 10pt">Subject to the terms and conditions of the Sales Agreement, Cantor will use its commercially
reasonable efforts consistent with its normal trading and sales practices and applicable state and
federal laws, rules and regulations and the rules of the NYSE MKT to sell on the Company&#146;s behalf
all of the shares of Common Stock requested to be sold by the Company. Cantor will offer the Common
Stock subject to the terms and conditions of the Sales Agreement on a daily basis or as otherwise
agreed upon by the Company and Cantor. The Company will designate the maximum amount of Common
Stock to be sold through Cantor on a daily basis or otherwise determine such maximum amount
together with Cantor. The Company may instruct Cantor not to sell Common Stock if the sales cannot
be effected at or above the price designated by the Company in any such instruction. The Company or
Cantor may suspend the offering of Common Stock being made through Cantor under the Sales Agreement
upon proper notice to the other party.


<P align="left" style="font-size: 10pt">The aggregate compensation payable to Cantor as sales agent shall be equal to 3.0% of the gross
sales price of the shares sold through it pursuant to the Sales Agreement. In addition, the Company
has agreed in the Sales Agreement to provide indemnification and contribution to Cantor against
certain liabilities, including liabilities under the Securities Act. In addition, the Company has
agreed to reimburse a portion of the expenses of Cantor in connection with this offering. The total
expenses of the offering payable by the Company, excluding commissions payable to Cantor under the
Sales Agreement, will be approximately $100,000.


<P align="left" style="font-size: 10pt">The offering of Common Stock pursuant to the Sales Agreement will terminate upon the earlier of (1)
the sale of all the shares of Common Stock offered under the prospectus supplement and the
accompanying prospectus pursuant to which the ATM Offering is made; and (2)&nbsp;the termination of the
Sales Agreement by the Company or by Cantor.


<P align="left" style="font-size: 10pt">The Sales Agreement is attached to this Current Report on Form 8-K as Exhibit&nbsp;10.1 and is
incorporated herein by reference. The foregoing description of the material terms of the Sales
Agreement does not purport to be complete and is qualified in its entirety by reference to the
exhibit attached hereto.&nbsp;&nbsp;


<P align="left" style="font-size: 10pt"><B>Item&nbsp;9.01 Financial Statements and Exhibits</B>


<P align="left" style="font-size: 10pt">(d)&nbsp;Exhibits.


<P align="left" style="font-size: 10pt">5.1 Opinion of Ballard Spahr LLP


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">10.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Controlled Equity Offering<sup>SM</sup> Sales Agreement by and between TransEnterix, Inc. and
Cantor Fitzgerald & Co. dated February&nbsp;20, 2015.</TD>
</TR>

</TABLE>


<P align="left" style="font-size: 10pt">23.1 Consent of Ballard Spahr LLP (included in Exhibit&nbsp;5.1)



<P align="center" style="font-size: 10pt; display: none">




<!-- v.121908 -->

<!-- PageBreak START -->
<P>
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<A HREF="#DOCUMENT_TOP">
<U>
<B>
<FONT SIZE="2">Top of the Form</FONT>
</B>
</U>
</A>
</DIV>
<!-- PageBreak END --><!-- SignatureHeader START -->
<P ALIGN="CENTER">
<FONT SIZE="2">
<B>
	SIGNATURES
</B>
</FONT>
</P>
<P ALIGN="LEFT">
<FONT SIZE="2">
	Pursuant to the requirements of the Securities Exchange Act of 1934, the
	registrant has duly caused this report to be signed on its behalf by the
	undersigned hereunto duly authorized.
</FONT>
</P>
<!-- SignatureHeader END --><!-- Signature START -->
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
<TR VALIGN="BOTTOM">
<TD WIDTH="19%">
	&nbsp;
</TD>
<TD WIDTH="34%">
	&nbsp;
</TD>
<TD WIDTH="3%">
	&nbsp;
</TD>
<TD WIDTH="1%">
	&nbsp;
</TD>
<TD WIDTH="43%">
	&nbsp;
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD COLSPAN="3" VALIGN="TOP" ALIGN="LEFT">
<FONT SIZE="2">
	TransEnterix, Inc.
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
<I>
	February 20, 2015
</I>
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
<I>
	By:
</I>
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
<I>
	/s/ Joseph P. Slattery
</I>
<BR>
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<HR SIZE="1" NOSHADE>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
<I>
	Name: Joseph P. Slattery
</I>
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
<I>
	Title: EVP and Chief Financial Officer
</I>
</FONT>
</TD>
</TR>
</TABLE>
</CENTER>
<!-- Signature END --><!-- PageBreak START -->
<P>
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<A HREF="#DOCUMENT_TOP">
<U>
<B>
<FONT SIZE="2">Top of the Form</FONT>
</B>
</U>
</A>
</DIV>
<!-- PageBreak END --><P ALIGN="CENTER">
<FONT SIZE="2">
	Exhibit&nbsp;Index
</FONT>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="60%">
<TR VALIGN="BOTTOM">
<TD WIDTH="8%">
	&nbsp;
</TD>
<TD WIDTH="15%">
	&nbsp;
</TD>
<TD WIDTH="77%">
	&nbsp;
</TD>
</TR>

<BR>
<TR VALIGN="BOTTOM">
<TD NOWRAP ALIGN="LEFT">
<FONT SIZE="1">
<B>
	Exhibit No.
</B>
</FONT>
</TD>
<TD>
<FONT SIZE="1">
	&nbsp;
</FONT>
</TD>
<TD NOWRAP ALIGN="LEFT">
<FONT SIZE="1">
<B>
	Description
</B>
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD NOWRAP ALIGN="CENTER">
<HR SIZE="1" NOSHADE>
</TD>
<TD>
<FONT SIZE="1">
	&nbsp;
</FONT>
</TD>
<TD NOWRAP ALIGN="CENTER">
<HR ALIGN="LEFT" SIZE="1" WIDTH="88%" NOSHADE>
</TD>
</TR>





<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" WIDTH="8%" nowrap>
<FONT SIZE="2">
<DIV ALIGN="LEFT">
	5.1
</DIV>
</FONT>
</TD>
<TD WIDTH="15%">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
<FONT SIZE="2">
Opinion of Ballard Spahr LLP
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" WIDTH="8%" nowrap>
<FONT SIZE="2">
<DIV ALIGN="LEFT">
	10.1
</DIV>
</FONT>
</TD>
<TD WIDTH="15%">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
<FONT SIZE="2">
Controlled Equity OfferingSM Sales Agreement by and between TransEnterix, Inc. and Cantor Fitzgerald & Co. dated February 20, 2015.
</FONT>
</TD>
</TR></TABLE></CENTER><!-- HTMLFooter START -->
</BODY>
</HTML>
<!-- HTMLFooter END -->
[{"type": "8-K", "sequence": "1", "filename": "htm_51334.htm", "description": "LIVE FILING", "secsgml_size_bytes": 14222}]
{"company-data": {"conformed-name": "TRANSENTERIX INC.", "cik": "0000876378", "assigned-sic": "3841", "irs-number": "112962080", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-19437", "film-number": "15636607"}, "business-address": {"street1": "635 DAVIS DRIVE", "street2": "SUITE 300", "city": "MORRISVILLE", "state": "NC", "zip": "27560", "phone": "919-765-8400"}, "mail-address": {"street1": "635 DAVIS DRIVE", "street2": "SUITE 300", "city": "MORRISVILLE", "state": "NC", "zip": "27560"}, "former-company": [{"former-conformed-name": "SafeStitch Medical, Inc.", "date-changed": "20080211"}, {"former-conformed-name": "CELLULAR TECHNICAL SERVICES CO INC", "date-changed": "19930328"}]}
TransEnterix, Inc. (Form: 8-K)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
February 20, 2015
TransEnterix, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
Delaware
0-19437
11-2962080
_____________________
(State or other jurisdiction
_____________
(Commission
______________
(I.R.S. Employer
of incorporation)
File Number)
Identification No.)
635 Davis Drive, Suite 300, Morrisville, North Carolina
27560
_________________________________
(Address of principal executive offices)
___________
(Zip Code)
Registrant's telephone number, including area code:
919-765-8400
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Top of the Form
Item 1.01 Entry into a Material Definitive Agreement.
On February 20, 2015, TransEnterix, Inc. (the "
Company
") entered into a Controlled Equity
Offering
SM
Sales Agreement (the "
Sales Agreement
") with Cantor Fitzgerald & Co.
("
Cantor
") pursuant to which the Company may sell from time to time, at its option, up to
an aggregate of $25.0 million of shares of the Company's common stock, $0.001 par value per share
(the "
Common Stock
"), through Cantor, as sales agent (the "
ATM Offering
"). Pursuant
to the Sales Agreement, sales of the Common Stock, if any, will be made under the Company's
previously filed and currently effective Registration Statement on Form S-3 (File No. 333-199998),
at market prices by any method that is deemed to be an "at the market" offering as defined in Rule
415 under the Securities Act, as amended (the "Securities Act"), including sales made directly on
the NYSE MKT and any other trading market for the Common Stock, and sales to or through a market
maker other than on an exchange.
Subject to the terms and conditions of the Sales Agreement, Cantor will use its commercially
reasonable efforts consistent with its normal trading and sales practices and applicable state and
federal laws, rules and regulations and the rules of the NYSE MKT to sell on the Company's behalf
all of the shares of Common Stock requested to be sold by the Company. Cantor will offer the Common
Stock subject to the terms and conditions of the Sales Agreement on a daily basis or as otherwise
agreed upon by the Company and Cantor. The Company will designate the maximum amount of Common
Stock to be sold through Cantor on a daily basis or otherwise determine such maximum amount
together with Cantor. The Company may instruct Cantor not to sell Common Stock if the sales cannot
be effected at or above the price designated by the Company in any such instruction. The Company or
Cantor may suspend the offering of Common Stock being made through Cantor under the Sales Agreement
upon proper notice to the other party.
The aggregate compensation payable to Cantor as sales agent shall be equal to 3.0% of the gross
sales price of the shares sold through it pursuant to the Sales Agreement. In addition, the Company
has agreed in the Sales Agreement to provide indemnification and contribution to Cantor against
certain liabilities, including liabilities under the Securities Act. In addition, the Company has
agreed to reimburse a portion of the expenses of Cantor in connection with this offering. The total
expenses of the offering payable by the Company, excluding commissions payable to Cantor under the
Sales Agreement, will be approximately $100,000.
The offering of Common Stock pursuant to the Sales Agreement will terminate upon the earlier of (1)
the sale of all the shares of Common Stock offered under the prospectus supplement and the
accompanying prospectus pursuant to which the ATM Offering is made; and (2) the termination of the
Sales Agreement by the Company or by Cantor.
The Sales Agreement is attached to this Current Report on Form 8-K as Exhibit 10.1 and is
incorporated herein by reference. The foregoing description of the material terms of the Sales
Agreement does not purport to be complete and is qualified in its entirety by reference to the
exhibit attached hereto.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
5.1 Opinion of Ballard Spahr LLP
10.1
Controlled Equity Offering
SM
Sales Agreement by and between TransEnterix, Inc. and
Cantor Fitzgerald & Co. dated February 20, 2015.
23.1 Consent of Ballard Spahr LLP (included in Exhibit 5.1)
Top of the Form
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
	registrant has duly caused this report to be signed on its behalf by the
	undersigned hereunto duly authorized.
TransEnterix, Inc.
February 20, 2015
By:
/s/ Joseph P. Slattery
Name: Joseph P. Slattery
Title: EVP and Chief Financial Officer
Top of the Form
Exhibit Index
Exhibit No.
Description
5.1
Opinion of Ballard Spahr LLP
10.1
Controlled Equity OfferingSM Sales Agreement by and between TransEnterix, Inc. and Cantor Fitzgerald & Co. dated February 20, 2015.